WHO ICTRP trial
A 52-week treatment, multicenter, randomized, double-blind, double dummy…
EUCTR2006-001954-28-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-001954-28-NL |
|---|---|
| Public title | A 52-week treatment, multicenter, randomized, double-blind, double dummy, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of indacaterol (300 & 600 µg o.d.) in patients with chronic obstructive pulmonary disease, using formoterol (12 µg b.i.d.) as an active control - N/A |
| Scientific title | A 52-week treatment, multicenter, randomized, double-blind, double dummy, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of indacaterol (300 & 600 µg o.d.) in patients with chronic obstructive pulmonary disease, using formoterol (12 µg b.i.d.) as an active… |
| Primary sponsor | NovartisPharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Estonia;Slovakia;Lithuania;United Kingdom;Italy;Hungary;Czech Republic;Belgium;Denmark;Netherlands;Germany;Latvia;Sweden |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) MedDRA version: 8.1 Level: LLT Classification code 10010952 Term: COPD |
| Interventions | Product Name: indacaterol Product Code: QAB149 Pharmaceutical Form: Inhalation powder, hard capsule Pharmaceutical form of the placebo: Inhalation powder, hard capsule Route of administration of the placebo: Inhalation use Trade Name… |
| Registration date | Jan 9, 2006 |
| Target size | 1716 |
| Secondary IDs | CQAB149B2334;N/A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: